FDA Advisory Committee Reform: Does Listening Session Suggest No Major Near-Term Changes?

FDA seeks feedback at 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special Government Employees, and public perception and understanding of the process.

Hearing
• Source: Shutterstock

The US Food and Drug Administration’s initiative to optimize the advisory committee process is going out for public comment, suggesting that despite ongoing reform efforts, major changes may not be implemented for some time. 

The FDA will hold a virtual listening session on 13 June to solicit feedback on the agency’s use and processes...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health